The Federal Trade Commission finally got some good news in its long battle to halt reverse payment settlements between brand and generic companies when an appeals court reversed a district court’s dismissal of a suit challenging K-Dur patent settlements.
In a July 16 decision, the U.S. Court of Appeals for the Third Circuit rejected the “scope of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?